INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 16, 2010 |
SVP & GM, Indust Ops&Prod Supp
Trans History: 359
|
SVP & GM, Indust Ops&Prod Supp | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,432 | -- | 45,432 |
| Dec 14, 2010 |
VP, Strat and Invest Relations
Trans History: 164
|
VP, Strat and Invest Relations | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- | 30,000 |
| Dec 14, 2010 |
SVP F&A, CFO, Treas & Asst Sec
Trans History: 645
|
SVP F&A, CFO, Treas & Asst Sec | Form 4/A | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- | 73,734 |
| Dec 14, 2010 |
VP Controller and Asst Treasur
Trans History: 372
|
VP Controller and Asst Treasur | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 3,320 | -- | 3,320 |
| Dec 14, 2010 |
VP Controller and Asst Treasur
Trans History: 372
|
VP Controller and Asst Treasur | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,180 | -- | 20,180 |
| Dec 14, 2010 |
SVP Clinical Development
Trans History: 208
|
SVP Clinical Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 3,264 | -- | 3,264 |
| Dec 14, 2010 |
SVP Clinical Development
Trans History: 208
|
SVP Clinical Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 28,736 | -- | 28,736 |
| Dec 14, 2010 |
VP Regul Devel & Med Safety
Trans History: 288
|
VP Regul Devel & Med Safety | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 3,264 | -- | 3,264 |
| Dec 14, 2010 |
VP Regul Devel & Med Safety
Trans History: 288
|
VP Regul Devel & Med Safety | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 26,736 | -- | 26,736 |
| Dec 14, 2010 |
Director, CEO and President, Ten Percent Owner
Trans History: 404
|
Director, CEO and President, Ten Percent Owner | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 125,000 | -- | 125,000 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.